BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

891 related articles for article (PubMed ID: 19808375)

  • 21. The ACE2-Ang (1-7)-Mas receptor axis attenuates cardiac remodeling and fibrosis in post-myocardial infarction.
    Wang J; He W; Guo L; Zhang Y; Li H; Han S; Shen D
    Mol Med Rep; 2017 Aug; 16(2):1973-1981. PubMed ID: 28656296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin II downregulates ACE2-mediated enhancement of MMP-2 activity in human cardiofibroblasts.
    Kuan TC; Chen MY; Liao YC; Ko L; Hong YH; Yen CY; Hsieh WY; Cheng KS; Wu CL; Lin CS
    Biochem Cell Biol; 2013 Dec; 91(6):435-42. PubMed ID: 24219285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AT1 receptor antagonist therapy preferentially ameliorated right ventricular function and phenotype during the early phase of remodeling post-MI.
    Nguyen QT; Colombo F; Clement R; Gosselin H; Rouleau JL; Calderone A
    Br J Pharmacol; 2003 Apr; 138(8):1485-94. PubMed ID: 12721104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin-converting enzyme 2 deficiency in whole body or bone marrow-derived cells increases atherosclerosis in low-density lipoprotein receptor-/- mice.
    Thatcher SE; Zhang X; Howatt DA; Lu H; Gurley SB; Daugherty A; Cassis LA
    Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):758-65. PubMed ID: 21252069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel role of aminopeptidase-A in angiotensin-(1-7) metabolism post myocardial infarction.
    Alghamri MS; Morris M; Meszaros JG; Elased KM; Grobe N
    Am J Physiol Heart Circ Physiol; 2014 Apr; 306(7):H1032-40. PubMed ID: 24464749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts.
    Noda K; Kobara M; Hamada J; Yoshifuji Y; Shiraishi T; Tanaka T; Wang J; Toba H; Nakata T
    J Cardiovasc Pharmacol; 2012 Aug; 60(2):140-9. PubMed ID: 22549451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin-converting enzyme-2 overexpression improves left ventricular remodeling and function in a rat model of diabetic cardiomyopathy.
    Dong B; Yu QT; Dai HY; Gao YY; Zhou ZL; Zhang L; Jiang H; Gao F; Li SY; Zhang YH; Bian HJ; Liu CX; Wang N; Xu H; Pan CM; Song HD; Zhang C; Zhang Y
    J Am Coll Cardiol; 2012 Feb; 59(8):739-47. PubMed ID: 22340266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors.
    Ishiyama Y; Gallagher PE; Averill DB; Tallant EA; Brosnihan KB; Ferrario CM
    Hypertension; 2004 May; 43(5):970-6. PubMed ID: 15007027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myocardial overexpression of TIMP3 after myocardial infarction exerts beneficial effects by promoting angiogenesis and suppressing early proteolysis.
    Takawale A; Zhang P; Azad A; Wang W; Wang X; Murray AG; Kassiri Z
    Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H224-H236. PubMed ID: 28550172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat.
    Ocaranza MP; Godoy I; Jalil JE; Varas M; Collantes P; Pinto M; Roman M; Ramirez C; Copaja M; Diaz-Araya G; Castro P; Lavandero S
    Hypertension; 2006 Oct; 48(4):572-8. PubMed ID: 16908757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin(1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart.
    Mercure C; Yogi A; Callera GE; Aranha AB; Bader M; Ferreira AJ; Santos RA; Walther T; Touyz RM; Reudelhuber TL
    Circ Res; 2008 Nov; 103(11):1319-26. PubMed ID: 18845809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II.
    Yamamoto K; Ohishi M; Katsuya T; Ito N; Ikushima M; Kaibe M; Tatara Y; Shiota A; Sugano S; Takeda S; Rakugi H; Ogihara T
    Hypertension; 2006 Apr; 47(4):718-26. PubMed ID: 16505206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterozygote loss of ACE2 is sufficient to increase the susceptibility to heart disease.
    Wang W; Patel VB; Parajuli N; Fan D; Basu R; Wang Z; Ramprasath T; Kassiri Z; Penninger JM; Oudit GY
    J Mol Med (Berl); 2014 Aug; 92(8):847-58. PubMed ID: 24728465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myocardial infarction increases ACE2 expression in rat and humans.
    Burrell LM; Risvanis J; Kubota E; Dean RG; MacDonald PS; Lu S; Tikellis C; Grant SL; Lew RA; Smith AI; Cooper ME; Johnston CI
    Eur Heart J; 2005 Feb; 26(4):369-75; discussion 322-4. PubMed ID: 15671045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced angiotensin II-induced cardiac and aortic remodeling in ACE2 knockout mice.
    Alghamri MS; Weir NM; Anstadt MP; Elased KM; Gurley SB; Morris M
    J Cardiovasc Pharmacol Ther; 2013 Mar; 18(2):138-51. PubMed ID: 23043153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased expression of angiotensin converting enzyme 2 in conjunction with reduction of neointima by angiotensin II type 1 receptor blockade.
    Igase M; Kohara K; Nagai T; Miki T; Ferrario CM
    Hypertens Res; 2008 Mar; 31(3):553-9. PubMed ID: 18497476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury.
    Wong DW; Oudit GY; Reich H; Kassiri Z; Zhou J; Liu QC; Backx PH; Penninger JM; Herzenberg AM; Scholey JW
    Am J Pathol; 2007 Aug; 171(2):438-51. PubMed ID: 17600118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of combination therapy with angiotensin I-converting enzyme inhibitor and angiotensin 1 receptor antagonist on ventricular remodeling and expression of endothelial nitric oxide synthase].
    Zhang RY; Huang YL; Sun YH
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(15):1053-6. PubMed ID: 16029550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of angiotensin-converting enzyme 2 exacerbates myocardial injury via activation of the CTGF-fractalkine signaling pathway.
    Song B; Zhang ZZ; Zhong JC; Yu XY; Oudit GY; Jin HY; Lu L; Xu YL; Kassiri Z; Shen WF; Gao PJ; Zhu DL
    Circ J; 2013; 77(12):2997-3006. PubMed ID: 24161906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin-converting enzyme (ACE and ACE2) imbalance correlates with the severity of cerulein-induced acute pancreatitis in mice.
    Liu R; Qi H; Wang J; Wang Y; Cui L; Wen Y; Yin C
    Exp Physiol; 2014 Apr; 99(4):651-63. PubMed ID: 24414175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.